Anthony Loera: Founder, RevGenetics
Anthony Loera
Founder & President, RevGenetics
- 🏢 Founder & President, RevGenetics (2007 to present)
- ⚙️ Background: Systems engineer, US hospice care sector
- 🧪 Focus: Longevity supplement formulation, purity standards, third-party verification
- 🤝 Works with: Dr. Hector Valenzuela, Ph.D., Chief Science Officer
- 📅 Operating since: 2007, 19 years in longevity supplements
Profile: Anthony Loera founded RevGenetics in 2007 after working as an engineer supporting one of the largest hospice organisations in the United States. He is not a research scientist. His role is operational: sourcing pharmaceutical-grade compounds, setting purity and dosage standards, commissioning third-party testing, and working with the company's scientific advisers so product claims stay inside what the published evidence supports.
Professional Timeline
- ▸ 2006 Engineer building systems for hospice healthcare teams, riding with nurses on home visits
- ▸ 2006 to 2007 Began studying longevity research with Dr. Hector Valenzuela, then researching telomeres and cellular ageing at UCLA
- ▸ 2007 Founded RevGenetics. First product was a 500mg trans-resveratrol capsule, a higher dose and purity than was generally available at the time
- ▸ 2007 to present Introduced micronization and later nano-micelle delivery technologies to the consumer longevity market
- ▸ Present Founder & President. Company profits part-fund longevity research and prospective Ph.D. students
Why RevGenetics Exists
In 2006 Anthony was an engineer at one of America's largest hospice organisations, building the technology systems its healthcare workers relied on. To design them properly he rode along with hospice nurses on home visits. One visit, to a five-year-old girl with less than six months to live, is the reason the company exists.
Around the same period he and his wife were told by fertility specialists at two hospitals that they were unlikely to have children. They went on to have two. That combination, close exposure to the end of life and a personal outcome that contradicted the medical consensus, is what moved him from building software to studying how to extend healthy years.
What Anthony Is Responsible For
Selecting raw material suppliers, setting the purity thresholds RevGenetics will accept, and commissioning independent third-party assay work. Certificates of analysis are published at /pages/certificates.
Setting doses against what published human studies actually used, rather than what is cheapest to produce. The original 2007 product was a 500mg trans-resveratrol capsule for this reason.
Bringing micronization and later liquid nano-micelle delivery to the consumer market, to address the poor absorption of compounds such as resveratrol and curcumin.
Scientific Review
Anthony writes from an operator's perspective. Scientific accuracy on RevGenetics content is the responsibility of Dr. Hector Valenzuela, Ph.D., Chief Science Officer, Fletcher Jones Endowed Chair in Molecular Biology and Biology Department Chair at Whittier College. Dr. Valenzuela holds a Ph.D. in Experimental Pathology from UCLA and has published on immunosenescence, telomere biology and T-cell ageing.
Where an article makes a claim about a compound, the underlying study is cited. RevGenetics products are dietary supplements. They are not intended to diagnose, treat, cure or prevent any disease.
Frequently Asked Questions
Is Anthony Loera a scientist or a doctor?
No. He is an engineer by training and the founder of RevGenetics. He does not hold a medical or research doctorate and does not give medical advice. Scientific review is handled by Dr. Hector Valenzuela, Ph.D.
What does he actually do at RevGenetics?
Sourcing and supplier selection, purity and dosage standards, commissioning third-party testing, delivery technology decisions, and company direction. He has held the Founder and President role since 2007.
Why did an engineer start a supplement company?
He worked as an engineer for a large US hospice organisation in 2006 and spent time on home visits with hospice nurses. That experience, and a personal fertility outcome that contradicted specialist expectations, led him to study longevity research and found RevGenetics in 2007.
How long has RevGenetics been operating?
Since 2007, which is 19 years as of 2026. Its first product was a 500mg trans-resveratrol capsule.
Where can I verify his background?
His LinkedIn profile is linked above. The full founding account is published at The RevGenetics Story, and company leadership is listed on About Us.
